Argipressin (Dimer, Antiparallel) consists of two argipressin molecules arranged in an antiparallel orientation, forming a higher-order assembly. Dimerization influences hydrodynamic properties, local conformation, and multivalent binding behavior. Researchers probe its aggregation dynamics and receptor-interaction profiles. Applications include supramolecular peptide studies, multivalent ligand design, and structural biophysics.
CAT No: Z10-101-168
Synonyms/Alias:2[L-cystyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparginyl-L-cystyl-L-prolyl-L-arginyl-glycinamide] (inter-disulfide bridges between 1 | 6’ and 1’ | 6 cysteines); Desmopressin Dimer(Antiparallel); Antiparallel Dimer-AVP; Anti-Parallel Dimer-Vasopressin; N0001-015255;
Argipressin (Dimer, Antiparallel) represents a specialized synthetic peptide construct, designed to mimic the dimeric, antiparallel configuration of the naturally occurring vasopressin analog. Featuring two argipressin units linked in an antiparallel orientation, this compound exhibits unique structural and functional properties, making it a valuable tool for advanced biochemical and pharmacological research. Its distinct molecular architecture allows researchers to explore the influence of dimerization and spatial arrangement on receptor binding, signal transduction, and peptide stability. The antiparallel dimerization of argipressin not only enhances its resistance to enzymatic degradation but also provides a robust platform for studying peptide-peptide interactions and conformational dynamics within biological systems. As a result, Argipressin (Dimer, Antiparallel) serves as a versatile reagent for investigating the myriad roles of vasopressin analogs across diverse scientific disciplines.
Receptor Binding Studies: In receptor pharmacology, the antiparallel dimer of argipressin offers a sophisticated model for dissecting the nuances of peptide-receptor interactions. By comparing the binding affinities and kinetics of the dimeric form with its monomeric counterpart, scientists can gain insights into the structural determinants that govern specificity and efficacy at vasopressin and related G protein-coupled receptors. This approach enables the elucidation of allosteric modulation, receptor dimerization, and potential cooperative binding phenomena, thereby advancing the fundamental understanding of peptide hormone signaling.
Peptide Stability and Enzymatic Degradation: Researchers investigating peptide therapeutics often employ Argipressin (Dimer, Antiparallel) to evaluate the impact of dimerization on metabolic stability. The antiparallel orientation confers enhanced resistance to proteolytic enzymes, making it an ideal model for probing degradation pathways and optimizing peptide drug design. By systematically studying the stability profiles of dimeric versus monomeric peptides, investigators can identify structural features that prolong bioactivity and inform the development of next-generation peptide-based therapeutics.
Signal Transduction Pathways: In cell signaling research, the antiparallel dimer serves as a potent tool for analyzing downstream effects of vasopressin analogs on intracellular pathways. Utilizing this dimeric construct, scientists can assess the activation of second messenger systems, such as cyclic AMP or calcium flux, and delineate the contributions of receptor clustering or oligomerization to signal amplification. This application is particularly valuable for mapping the molecular circuitry underlying hormone-responsive cellular processes and for identifying potential targets for pharmacological modulation.
Structural Biology and Conformational Analysis: The unique antiparallel arrangement of Argipressin (Dimer, Antiparallel) renders it an excellent candidate for structural studies using techniques like nuclear magnetic resonance (NMR) spectroscopy, X-ray crystallography, or computational modeling. By characterizing the three-dimensional conformation and dynamic behavior of the dimer, researchers can unravel the principles governing peptide folding, intermolecular interactions, and the effects of dimerization on biological activity. These insights are instrumental in guiding the rational design of novel peptide architectures with tailored functional properties.
Peptide-Peptide Interaction Research: Beyond its direct biological applications, the dimeric form of argipressin is employed in studies focused on peptide aggregation, self-assembly, and intermolecular recognition. Its antiparallel configuration provides a model system for investigating how peptide dimers form, stabilize, and interact within complex biological environments. Such research is critical for understanding the mechanisms of peptide aggregation in health and disease, as well as for engineering new biomaterials with programmable assembly properties.
Argipressin (Dimer, Antiparallel) continues to drive innovation across these diverse scientific applications, offering a robust and adaptable platform for probing the intricate relationships between peptide structure, stability, and function. Whether utilized in receptor pharmacology, stability testing, signal transduction analysis, structural biology, or peptide aggregation studies, this antiparallel dimeric construct empowers researchers to advance their understanding of peptide science and to pioneer new approaches in molecular design and functional analysis.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More